Cervical Cancer Screening for Black Women: What to Know

Cervical cancer is almost entirely preventable. Nearly all of it, about 91% of cases, comes from a persistent infection with a high-risk type of human papillomavirus (HPV), and HPV is something the immune system clears on its own in most people. The cancer takes years to develop, which is exactly why screening works: a Pap or HPV test can catch the changes long before they turn into cancer. Yet Black women in the United States die of cervical cancer at roughly twice the rate of white women, and they are more often diagnosed once the disease has already spread. The gap is not about biology. It is about who gets screened on time, and who gets the follow-up after an abnormal result.

For years the standard mortality numbers undercounted the gap. Death rates are normally calculated using every woman in the population as the denominator, including women who have had a hysterectomy and no longer have a cervix, so they cannot get cervical cancer. Black women have hysterectomies at higher rates, which artificially deflated their death rate. In 2017, Anne Rositch and Anna Beavis at Johns Hopkins recalculated the numbers after removing women without a cervix from the count. The corrected death rate for Black women rose to 10.1 per 100,000, compared with 4.7 per 100,000 for white women. The uncorrected figures had hidden 44% of the true racial disparity.

The stage at which the cancer is found matters as much as the death rate. Black women are more likely to be diagnosed after the cancer has already spread beyond the cervix, when it is harder to treat. One analysis of national data found that after accounting for age, marital status, year of diagnosis, and neighborhood poverty, Black women were still 34% more likely than white women to be diagnosed at a later stage. Earlier detection is the whole point of screening, and it is where the disparity opens up.

Screening starts at age 21, regardless of when you became sexually active. The U.S. Preventive Services Task Force lays out the schedule:

• Ages 21 to 29: a Pap test (cervical cytology) every 3 years.
• Ages 30 to 65: the preferred option is now a high-risk HPV test every 5 years, which can be clinician-collected or patient-collected. Alternatives are a Pap test every 3 years, or HPV and Pap together (co-testing) every 5 years.
• Over 65: you can usually stop screening if you have had adequate normal results and no history of serious cervical changes.

The shift toward HPV primary testing reflects what the science shows: testing for the virus that causes the cancer catches more disease earlier than looking at cells alone. The HPV test is the front line; the Pap looks for cell changes that have already started.

In May 2024, the FDA approved HPV self-collection, where you collect your own vaginal sample with a swab in a clinic instead of having a clinician perform a speculum exam. In May 2025, the FDA cleared the first at-home self-collection kit, available by prescription. This matters for women who avoid the pelvic exam because of discomfort, past trauma, or a lack of trust built over real experiences of dismissive care. The research is reassuring: self-collected HPV samples detect precancer about as well as clinician-collected ones. If a fear of the exam has kept you from screening, self-collection removes that barrier without lowering the protection.

The current vaccine, Gardasil 9, protects against the seven high-risk HPV types responsible for most cervical cancers, plus the two types that cause most genital warts. The CDC routinely recommends it at age 11 or 12, and it can start as early as 9. Vaccination is recommended for everyone through age 26 who was not adequately vaccinated earlier. For adults ages 27 to 45, the CDC recommends shared decision-making: the vaccine offers less benefit at this age because many adults have already been exposed to HPV, but some people will still benefit, and it is a conversation worth having with your clinician. The vaccine prevents infection; it does not treat an infection you already have, which is why screening still matters even if you are vaccinated.

It is not that Black women skip the first test. Black women get an initial Pap at rates similar to or higher than white women. The gap opens after that, in the parts of the system that are easy to lose people in:

• Follow-up after an abnormal result. An abnormal Pap or positive HPV test only protects you if you complete the next step. Black women are less likely to get timely follow-up testing and colposcopy, and that delay is where a treatable lesion becomes a late-stage cancer.
• Access and insurance. Gaps in coverage, lost work hours, transportation, and clinic distance all stack up between an abnormal result and the appointment that resolves it.
• Medical mistrust, earned. Decades of dismissive and harmful care give many Black women good reason to be wary of the system. A clinician who listens and explains is not a luxury here; it changes whether the follow-up happens.

If finding a clinician you trust is the barrier, that is fixable. You can find a Black OB-GYN near you and search our provider directory for clinicians who specialize in caring for Black patients.

An abnormal screening result is not a cancer diagnosis. Most abnormal results mean either that a high-risk HPV type was found or that some cervical cells look slightly changed. Depending on the result, the next step is repeat testing in a year, or a colposcopy, an in-office exam where the clinician uses a lighted magnifier to look closely at the cervix and may take a small tissue sample (biopsy). If precancerous cells are found, they can be removed with a quick outpatient procedure, which is precisely how cervical cancer gets prevented. The danger is not the abnormal result. The danger is not coming back for the follow-up. Put the next appointment on the calendar before you leave.

Three steps protect you. First, know your last screening date and whether you are due; if you are over 30, ask whether HPV primary testing or self-collection is an option for you. Second, if you have ever had an abnormal result, confirm you completed every follow-up step and are not lost in the system. Third, if past experiences have made you avoid the gynecologist, find a clinician who treats you as a partner. Use our directory to find a Black or Black-serving OB-GYN who takes your insurance and listens. The screening is free under most insurance plans as a preventive service. The hardest part is walking in the door, and going back when they ask you to.